Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain

Infection and Immunity

Volumn 65, Issue 7, 1997, Pages 2941-2949

  Ryan, Edward T ^a   Butterton, Joan R ^a   Smith, Rex Neal ^a   Carroll, Patricia A ^a   Crean, Thomas I ^a   Calderwood, Stephen B ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM TOXIN; TOXIN ANTIBODY;

ARTICLE; BACTERIAL COLONIZATION; CLOSTRIDIUM DIFFICILE; HISTOLOGY; IMMUNITY; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PSEUDOMEMBRANOUS COLITIS; VACCINATION; VIBRIO CHOLERAE;

EID: 0030987748     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.7.2941-2949.1997     Document Type: Article

References (63)

1. Acheson, D. W., M. M. Levine, J. B. Kaper, and G. T. Keusch. 1996. Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. Infect. Immun. 64:355-357.
2. Allo, M., J. Silva, Jr., R. Fekety, G. D. Rifkin, and H. Waskin. 1979. Prevention of clindamycin-induced colitis in hamsters by Clostridium sordelli antitoxin. Gastroenterology 76:351-355.
3. Backstrom, M., M. Lebens, F. Schodel, and J. Holmgren. 1994. Insertion of a HIV-1 neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit. Gene 149:211-217.
4. Butterton, J. R., D. T. Beattie, C. L. Gardel, P. A. Carroll, T. Hyman, K. P. Killeen, J. J. Mekalanos, and S. B. Calderwood. 1995. Heterologous antigen expression in Vibrio cholerae vector strains. Infect. Immun. 63:2689-2696.
5. Butterton, J. R., S. A. Boyko, and S. B. Calderwood, 1993, Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains. Vaccine 11:1327-1335.
6. Corthier, G., M. C. Muller, T. D. Wilkins, D. Lyerly, and R. L'Haridon. 1991. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A. Infect. Immun. 59;1192-1195.
7. Cray, W. C., Jr., E. Tokunaga, and N. F. Pierce. 1983. Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. Infect. Immun. 41:735-741.
8. Dillon, S. T., E. J. Rubin, M. Yakubovich, C. Pothoulakis, J. T. LaMont, L. A. Feig, and R. J. Gilbert. 1995. Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect. Immun. 63:1421-1426,
9. Dove, C. H., S. Z. Wang, S. B. Price, C. J. Phelps, D. M. Lyerly, T. D. Wilkins, and J. L. Johnson. 1990. Molecular characterization of the Clostridium difficile toxin A gene. Infect. Immun, 58:480-488.
10. Fekety, R., K. H. Kim, D. Brown, D. H. Batts, M. Cudmore, and J. Silva, Jr. 1981. Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment. Am. J. Med. 70:906-908.
11. Formal, S. B., D. Kundel, H. Schnelder, N. Kunev, and H. Sprinz. 1961. Studies with Vibrio cholerae in the ligated loop of the rabbit intestine. Br. J. Exp. Path. 42:504-510.
12. Frey, S. M., and T. D. Wilkins. 1992. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect. Immun. 60:2488-2492.
13. Gentschev, I., J. Hess, and W. Goebel, 1990. Change in the cellular localization of alkaline phosphatase by alteration of its carboxy-terminal sequence. Mol. Gen. Genet. 222:211-216.
14. Gentschev, I., Z. Sokolovic, S. Kohler, G. F. Krohne, H. Hof, J. Wagner, and W. Goebel. 1992. Identification of p60 antibodies in human sera and presentation of this listerial antigen on the surface of attenuated salmonellae by the HlyB-HlyD secretion system. Infect. Immun. 60:5091-5098.
15. Gentschev, I., Z. Sokolovic, H. J. Mollenkopf, J. Hess, S. H. Kaufmann, M. Kuhn, G. F. Krohne, and W. Goebel. 1995. Salmonella strain secreting active listeriolysin changes its intracellular localization. Infect. Immun. 63:4202-4205.
16. Goldberg, M. B., S. A. Boyko, and S. B. Calderwood. 1991. Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 88:1125-1129.
17. Gray, L., N. Mackman, J. M. Nicaud, and I. B. Holland. 1986. The carboxyterminal region of haemolysin 2001 is required for secretion of the toxin from Escherichia coli. Mol. Gen. Genet. 205:127-133.
18. Hess, J., I. Gentschev, W. Goebel, and T. Jarchau. 1990. Analysis of the haemolysin secretion system by PhoA-HlyA fusion proteins. Mol. Gen. Genet. 224:201-208.
19. Hess, J., I. Gentschev, D. Miko, M. Welzel, C. Ladel, W. Goebel, and S. H. Kaufmann. 1996. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl, Acad. Sci. USA 93:1458-1463.
20. Holmgren, J., C. Czerkinsky, N. Lycke, and A. M. Svennerholm. 1994. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier and adjuvant. Am. J. Trop. Med. Hyg. 50(Suppl.):42-54.
21. Hovde, C. J., S. B. Calderwood, J. J. Mekalanos, and R. J. Collier. 1988. Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I. Proc. Natl. Acad. Sci. USA 85:2568-2572.
22. Johnson, S., W. D. Sypura, D. N. Gendlng, and E. N. Janoff. 1993. Neutralization of a bacterial enterotoxin by systemic IgA in response to mucosal infection. J. Immunol. 150:117A, abstr. 657.
23. Kaatz, G. W., S. D. Gitlin, D. R. Schaberg, K. H. Wilson, C. A. Kauffman, S. M. Seo, and R. Fekety. 1988. Acquisition of Clostridium difficile from the hospital environment. Am. J. Epidemiol. 127:1289-1294.
24. Kaper, J. B., J. Michalski, J. M. Ketiey, and M. M. Levine. 1994. Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD103-HgR. Infect. Immun. 62:1480-1483.
25. Kelly, C. P., C. Pothoulakis, and J. T. LaMont. 1994. Clostridium difficile colitis. N. Engl. J. Med. 330:257-262.
26. Kelly, C. P., C. Pothoulakis, J. Orellana, and J. T. LaMont. 1992. Human colonie aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding. Gastroenterology 102:35-40.
27. Ketley, J. M., T. J. Mitchell, D. C. Candy, D. W. Burdon, and J. Stephen. 1987. The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits. J. Med. Microbiol. 24: 41-52.
28. Kim, P. H., J. P. Iaconis, and R. D. Rolfe. 1987. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect. Immun. 55:2984-2992.
29. Krivan, H. C., G. F. Clark, D. F. Smith, and T. D. Wilkins. 1986. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Galα1-3Ga1β1-4GlcNAc. Infect. Immun. 53: 573-581.
30. Langermann, S., S. R. Palaszynski, J. E. Burlein, S. Koenig, M. S. Hanson, D. E. Briles, and C. K. Stover. 1994. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille CalmetteGuerin vaccines expressing pneumococcal surface protein A. J. Exp. Med. 180:2277-2286.
31. Leung, D. Y., C. P. Kelly, M. Boguniewicz, C. Pothoulakis, J. T. LaMont, and A. Flores. 1991. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J. Pediatr. 118:633-637.
32. Levine, M. M., R. E. Black, M. L. Clements, L. Cisneros, D. R. Nalin, and C. R. Young. 1981. Duration of infection-derived immunity to cholera. J. Infect., Dis. 143:818-820.
33. Levine, M. M., J. B. Kaper, D. Herrington, J. Ketley, G. Losonsky, C. O. Tacket, B. Tall, and S. Cryz. 1988. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD103 and CVD103-HgR. Lancet 11:467-470.
34. Lima, A. A., D. M. Lyeriy, T. D. Wilkins, D. J. Innes, and R. L. Guerrant. 1988. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect. Immun. 56:582-588.
35. Lyeriy, D. M., S. M. Frey, and T. D. Wilkins. 1990. Vaccination against lethal Clostridium difficile enteritis with a nontoxigenic recombinant peptide of toxin A. Curr. Microbiol. 21:29-33.
36. Lyeriy, D. M., H. C. Krivan, and T. D. Wilkins. 1988, Clostridium difficile: its disease and toxins. Clin. Microbiol. Rev. 1:1-18.
37. Mackman, N., K. Baker, L. Gray, R. Haigh, J. M. Nicaud, and I. B. Holland. 1987. Release of a chimeric protein into the medium from Escherichia coli using the C-terminal secretion signal of a hemolysin. EMBO J. 6:2835-2841.
38. McFarland, L. V., M. E. Mulligan, R. Y. Kwok, and W. E. Stamm. 1989. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 320:204-210.
39. Mekalanos, J. J. 1983. Duplication and amplification of toxin genes in Vibrio cholerae. Cell 35:253-263.
40. Mekalanos, J. J., D. J. Swartz, G. D. Pearson, N. Harford, F. Groyne, and M. de Wilde. 1983. Cholera toxin genes: nuclcotide sequence, deletion analysis and vaccine development. Nature 306:551-557.
41. Mitchell, T. J., J. M. Ketley, S. C. Haslam, J. Stephen, D. W. Burdon, D. C. Candy, and R. Daniel. 1986. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut 27:78-85.
42. Mitty, R. D., and J. T. LaMont. 1994. Clostridium difficile diarrhea: pathogenesis, epidemiology, and treatment. Gastroenterologist 2:61-69.
43. Pearson, G. D., A. Woods, S. L. Chiang, and J. J. Mekalanos. 1993. CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc. Natl. Acad. Sci. USA 90:3750-3754,
44. Pierce, N. F., W. C. Cray, Jr., J. B. Kaper, and J. J. Mekalanos. 1988. Determinants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits. Infect. Immun. 56:142-148.
45. Pierce, N. F., J. B. Kaper, J. J. Mekalanos, and W. C. Cray, Jr. 1985. Role of cholera toxin in enteric colonization by Vibrio cholerae O1 in rabbits. Infect. Immun. 50:813-816.
46. Price, S. B., C. J. Phelps, T. D. Wilkins, and J. L. Johnson. 1987. Cloning of the carbohydrate-binding portion of the toxin A gene of Clostridium difficile. Curr. Microbiol. 16:55-60.
47. Quiding, M., I. Nordstrom, A. Kilander, G. Andersson, L. A. Hanson, J. Holmgren, and C. Czerkinsky. 1991. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J. Clin. Invest. 88:143-148.
48. Ryan, E. T., J. R. Butterton, T. Zhang, M. A. Baker, S. L. Stanley, Jr., and S. B. Calderwood. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP-12) fused to the cholera toxin B subunit induces systemic and mucosal anti-amebic and anti-K cholerae antibody responses in mice. Infect. Immun., in press.
49. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
50. Sanchez, J., A.-M. Svennerholm, and J. Holmgren. 1988. Genetic fusion of a non-toxic heat stable enterotoxin-related decapeptidc antigen to cholera toxin B-subunit. FEBS Lett. 241:110-114.
51. Sauerborn, M., and C. von Eichel-Streiber. 1990. Nucleotide sequence of Clostridium difficile toxin A. Nucleic Acids Res. 18:1629-1630,
52. Schodel, F., H. Will. S. Johansson, J. Sanchez, and J. Holmgren. 1991, Synthesis in Vibrio cholerae and secretion of hepatitis B virus antigens fused to Escherichia coli heat labile enterotoxin suhunit B. Gene 99:255-259.
53. Sigel, S. P., and S. M. Payne. 1982. Effect of iron limitation on growth, siderophore production, and expression of outer membrane proteins of Vibrio cholerae. J. Bacteriol. 150:148-155.
54. Tacket, C. O., G. Losonsky, J. P. Nataro, L. Comstock, J. Michalski, R. Edelman, J. B. Kaper, and M. M. Levine. 1995. Initial clinical studies of CVD112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J. Infect. Dis. 172:883-886.
55. Taylor, D. N., K. P. Killeen, D. C. Hack, J. R. Kenner, T. S. Coster, D. T. Beattie, J. Ezzell, T. Hyman, A. Trofa, M. H. Sjogren, A. Friedlander, J. J. Mekalanos, and J. C. Sadoff. 1994. Development of a live, oral attenuated vaccine against E1 Tor cholera. J. Infect. Dis. 170:1518-1523.
56. Tucker, K. D., and T. D. Wilkins. 1991. Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect. Immun. 59:73-78.
57. Tzschaschel, B. D., C. A. Guzman, K. N. Timmis, and V. de Lorenzo. 1996. An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium aroA. Nat. Biotcchnol. 14:765-769.
58. von Eichel-Streiber, C., and M. Sauerborn. 1990. Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of strcptococcal glycosyltransferases. Gene 96:107-113.
59. Wagner, W., M. Vogel, and W. Goebel. 1983. Transport of hemolysin across the outer membrane of Escherichia coli requires two functions. J. Bacteriol. 154:200-210.
60. Waldor, M. K., and J. J. Mekalanos. 1994. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. J. Infect. Dis. 170:278-283.
61. Wandersman, C., and P. Delepelaire. 1990. TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc. Natl. Acad. Sci. USA 78:4776-4780.
62. Warny, M., J. P. Vaerman, V. Avesani, and M. Delmee. 1994. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect. Immun. 62:384-389.
63. Wren, B. W., R. R. Russell, and S. Tabaqchali. 1991. Antigcnic cross-reactivity and functional inhibition by antibodies to Clostridium difficile toxin A, Streptococcus mutons glucan-binding protein, and a synthetic peptide. Infect. Immun. 59:3151-3155.